SABINSA CORPORATION V. HERBAKRAFT, INC.

District Court, D. New Jersey·Decided December 6, 2022·No. 1:14-cv-04738·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY CAMDEN VICINAGE ___________________________________________ : SABINSA CORPORATION, : Plaintiffs, : v. : Civil Action No: 14-cv-04738 RBK-SAK : HERBAKRAFT, INC., and PRAKRUTI : ORDER AND OPINION PRODUCTS PVT. LTD., : Defendants. : : ___________________________________________ : KUGLER, United States District Judge: ORDER THE COURT HAVING REVIEWED defendant Prakruti’s motion dated 4 May 2022 to appeal the Magistrate Judge’s order of 20 April 2022 granting plaintiff Sabinsa’s request for attorneys’ fees and all relevant submissions related to Prakruti’s motion; IT IS HEREBY ORDERED: Prakruti’s motion (ECF Doc. 287-1) dated 4 May 2022 is DENIED. OPINION Before the Court is defendant’s [“Prakruti”] motion [“the motion”] (ECF Doc. 287-1) dated 4 May 2022 to appeal the Magistrate Judge’s order [“the order”] of 20 April 2022 granting plaintiff’s [“Sabinsa’”] request for attorneys’ fees (ECF Doc. 287). For the reasons set forth below, and for good cause shown, and without oral argument as permitted by Fed. R. Civ. Proc. 78, the motion is hereby DENIED. 1.0 BACKGROUND AND PROCEDURAL HISTORY This Court assumes the parties’ familiarity with the factual background and procedural history of this matter. Both parties have conducted business in supplying nutraceutical products containing curcuminoids. Sabinsa held U.S. Pat. No. 5,861,415 (“the ‘415 patent”), which claims processes of isolating and administering curcuminoid products and a single product by process claim for a curcuminoid product. In March 2014, Sabinsa sued Prakruti for infringing the ‘415 patent. On 7 January 2015 the parties executed a settlement agreement (“the Agreement”) and terminated the infringement suit. The Agreement defined Prakruti’s own curcuminoid products as infringing under the ‘415 patent, affirmatively prohibited Prakruti’s possible validity challenge of the ‘415 patent, and obligated Prakruti to pay a royalty for any subsequent sales of Prakruti curcuminoid products. The ‘415 patent expired on or about 12 July 2016. On 28 October 2016, Sabinsa, believing Prakruti had continued to sell curcuminoid products without paying the required royalty, sought to open infringement action to enforce the Agreement. (ECF Docs. 38 and 29). This Court granted Sabinsa’s motion for the sole purpose of engaging in a limited discovery process to determine if Prakruti had breached the Agreement. This Court’s Re- Opening Order (ECF Doc. 76) empowered Sabinsa to obtain samples of Prakruti’s products for testing of infringement and other information about Prakruti’s post-Agreement sales. Eventually, Sabinsa sought an order (ECF Doc.141) from the Magistrate Judge declaring Prakruti’s spoliation (including the destruction of the tell-tale Prakruti samples) and sought sanctions against Prakruti for all spoliation issues, which also include misrepresentations, withholding of evidence and, and an overall disregard for the Court’s Re-Opening Order. On 17 December 2018, in her Spoliation Order (ECF Doc. 220), the Magistrate Judge held Prakruti had spoliated samples of its sold products, thereby obfuscating its possible infringement, and granted Sabinsa the attorneys’ fees and costs it had incurred in demonstrating the spoliation and bringing motions related to it. On 31 December 2018, Prakruti filed a motion (ECF Doc. 221) seeking reconsideration of the spoliation order and specifically asked the Magistrate Judge to reverse her findings, to wit: Sabinsa’s spoliation sanctions, attorneys’ fees, and the assurance of an adverse inference to the jury. On 2 August 2019, the Magistrate Judge denied the reconsideration motion (ECF Doc. 235). Prakruti then appealed the Spoliation Order to this Court. (ECF Doc. 236). This Court denied Prakruti’s appeal in part and remanded to the Magistrate Judge (ECF Nos. 278 and ECF No. 279) on the issue of attorney fees calculation for Sabinsa’s patent counsel, Arent Fox LLP (“Arent Fox”), located in Washington, DC. After entertaining further argument by the parties on the issue of recalculation of Sabinsa’s attorney fees for the spoliation discovery, on 4 April 2022, the Magistrate Judge issued her re-calculation opinion and order (ECF Doc. 286), which adjusted the calculation for Arent Fox’s fees from $879,724.20 to $878,548.56, that is, reduced the fees by a total of $1,173.64. On 4 May 2022, Prakruti timely filed this motion to appeal the fee recalculation. (ECF Doc. 287). The parties timely filed their opposition (ECF Doc. 291) and reply (ECF Doc. 292).

1.0 PARTIES’ CONTENTIONS 2.1 Prakruti 1) The Magistrate Judge erred in her determination of reasonable rates for Arent Fox’s attorney fees because she wrongly used the attorney fee rates for the Philadelphia, Pennsylvania and Wilmington, Delaware areas to calculate legal work done in the Camden, New Jersey and southern New Jersey area. 2) In equating the third quartile attorney fee rates for Philadelphia and Wilmington to those for Camden, NJ, the Magistrate Judge wrongfully considered the following: Prakruti’s spoliation misconduct, the complexity of the litigation, and prior sanctions on Prakruti, and thereby abused her discretion in calculating the Arent Fox’s legal fees in her Opinion and Order (ECF Doc. 286). 3) Had the Magistrate Judge not taken into account these punishing factors in 2, the Magistrate Judge would have properly reduced the lodestar1 calculation by an amount commensurate with a proper consideration of the rate of the forum where the fees were incurred.

2.2 Sabinsa 1) The Magistrate Judge properly selected an applicable forum rate from the Real Rate Report provided by Prakruti’s own expert and properly applied third quartile rates. 2) The Magistrate Judge properly calculated the lodestar amount.

2.0 LEGAL STANDARD A United States Magistrate Judge may hear and issue a decision on a non-dispositive, pre-trial matter pending before the court. 28 U.S.C. § 636(b)(1)(A); Cardona v. General Motors Corp., 942 F.Supp. 868, 970 (D.N.J. 1996); see Fed. R. Civ. P. 72(a). The district court may reverse a magistrate judge’s decision only if it is “clearly erroneous or contrary to law.” 28 U.S.C. § 636(b)(1)(A); Fed. R. Civ. P. 72(a); L. Civ. R. 72.1(c)(1)(A). The appellant has the burden to show the magistrate judge’s decision meets the standard for reversal. Exxon Corp. v. Halcon Shipping Co., 156 F.R.D. 589, 591 (D.N.J. 1994). A district court must apply the “clearly erroneous” standard to a magistrate judge’s fact finding. Lithuanian Commerce Corp. v. Sara Lee Hoisery, 177 F.R.D. 205, 213 (D.N.J. 1997) (citing Lo Bosco v. Kure Eng’g Ltd., 891 F.Supp. 1035, 1037 (D.N.J. 1995). A magistrate judge’s fact finding is clearly erroneous when, “although there is evidence to support it, the reviewing court on the entire evidence is left with the definite and firm conviction that a mistake has been committed.” U.S. v. U.S. Gypsum Co., 333 U.S. 364, 395 (1948). Mere disagreement with the magistrate judge’s fact finding is insufficient for reversal. Haines v. Liggett Grp. Inc., 975 F.2d 81, 91 (3d Cir. 1992). Further, a district judge must not consider

Free access — add to your briefcase to read the full text and ask questions with AI

SABINSA CORPORATION V. HERBAKRAFT, INC., (D.N.J. 2022).

SABINSA CORPORATION V. HERBAKRAFT, INC. (SABINSA CORPORATION V. HERBAKRAFT, INC.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related